India Gains Zero-Duty Access to 70% of Global GDP, Says Piyush Goyal

Union Commerce Minister Piyush Goyal announced that India has secured market access to 70% of global GDP, largely at zero duty, through nine Free Trade Agreements concluded in the last three years. He urged Indian medtech startups to leverage these agreements and look beyond the domestic market to scale their affordable innovations globally. Goyal emphasized that the Commerce Ministry and India's missions in over 190 countries are ready to support startups in participating in international fairs and collaborating with global firms. He also highlighted ongoing efforts to establish new educational institutes, including three more NIPERs and a National Institute of Design in East India.

Key Points: India's Market Access to 70% Global GDP at Zero Duty

  • 9 FTAs concluded in 3 years
  • Covers 38 high-income countries
  • Medtech startups urged to target global markets
  • Support from 190+ Indian missions abroad
  • Focus on affordable, scalable innovations
2 min read

India now has market access to 70 pc of global GDP at mostly zero duty: Piyush Goyal

Commerce Minister Piyush Goyal announces India's FTAs now provide zero-duty access to 70% of global GDP, urging medtech startups to go global.

"India now has market access to 70 per cent of global GDP, in most cases at zero duty for domestic products - Piyush Goyal"

New Delhi, Feb 12

India now has market access to 70 per cent of global GDP, in most cases at zero duty for domestic products, Union Commerce and Industry Minister Piyush Goyal said on Thursday.

Speaking at an event here, Goyal said that nine Free Trade Agreements (FTAs) have been concluded in the last three years, covering 38 countries with strong per capita incomes, and most developed markets now have trade arrangements with India.

"Agreements include the 27-nation EU bloc, four-nation EFTA bloc, the UK, Australia and New Zealand, the United States of America, while Japan and Korea were concluded earlier, along with ASEAN nations," the minister said.

He also urged medtech startups to look beyond the domestic market, leverage India's expanding trade agreements covering nearly 70 per cent of global GDP, and scale affordable innovations to serve both India and the world.

The minister emphasised that affordable, scalable medical technology can help reach the remotest parts of India and also access global markets across Africa, Latin America, Central Asia, Southeast Asia and developed economies.

According to the minister, startups should not limit themselves to the domestic market and should participate in global fairs and exhibitions.

He assured that Commerce Ministry would support delegations and that India's missions in over 190 countries are available to assist innovators. He also encouraged collaboration with global companies, present in over 100 countries, to access developed markets.

Affordable and scalable medtech products can reduce costs and improve quality through economies of scale. Referring to startups present at the programme, he noted that many had secured CDSCO approvals and some were on the verge of receiving FDA approvals, enabling them to expand internationally.

Innovation must address India's day-to-day needs and ground-level imperatives.

The minister underlined the importance of showcasing success stories and urged 'Startup India', the private sector and the media to encourage entrepreneurs, including those who may not succeed initially.

Three more National Institutes of Pharmaceutical Education and Research (NIPERs) are being established alongside the upgradation of seven existing NIPERs. A new National Institute of Design (NID) will be set up in East India, with states competing to provide the best proposal.

- IANS

Share this article:

Reader Comments

A
Arjun K
Good step, but the real test is on the ground. Are our small manufacturers equipped to meet international quality standards and scale up production? The government must ensure support reaches the actual SMEs, not just the big corporates.
R
Rohit P
Focusing on medtech for remote areas is the need of the hour. If our innovations can serve villages in Bihar and then be sold in Africa, that's true jugaad with global impact! Hope the new NIPERs and NID boost R&D.
S
Sarah B
As someone working in the export sector, this simplifies so much. The duty advantage is significant. The key now is efficient logistics and cutting red tape at ports to actually deliver on this promise.
V
Vikram M
FTAs with the UK, EU, and EFTA are major achievements. But we must be cautious and ensure our domestic industries, especially agriculture and dairy, are protected. It should be a two-way street.
K
Kavya N
Love the emphasis on affordable medtech! India has the potential to become the pharmacy *and* the medical equipment hub of the world. This can create so many jobs and bring foreign exchange. Let's go!

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50